Angela Yulia

Dr. Angela Yulia

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Early Human Development
Verified
Journal Article
Closed access
AYAngela Yulia
Angela Yulia
PWPaul Winyard
Paul Winyard

2 June 2020 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
AYAngela Yulia
Angela Yulia
RNRaffaele Napolitano
Raffaele Napolitano
AAA. Aiman
A. Aiman
DDD. Desai
D. Desai
NJN. Johal
N. Johal
PWP. J. D. Winyard
P. J. D. Winyard
Objective: Hyperechogenic kidneys are a relatively rare antenatal finding, which can generate significant parental anxiety due to uncertain prognosis. We report on the perinatal and infant outcomes of a large cohort of fetuses with antenatally diagnosed hyperechogenic kidneys.Methods: This was a retrospective analysis of all cases diagnosed prenatally with hyperechogenic kidneys between 2002 and 2017 in a large tertiary fetal medicine unit. Hyperechogenicity was defined as kidney parenchyma with greater echogenicity than that of the liver. Pregnancy, pathological and postnatal outcomes were collected from hospital and general practitioner records up to 1 year of age. Abnormal renal outcome was defined as elevated creatinine beyond 6 months of age, hypertension requiring medication or major kidney surgery, such as nephrectomy. Severe abnormal renal outcome was defined as the need for dialysis or kidney transplant at any stage.Results: Three‐hundred and sixteen fetuses with hyperechogenic kidneys were identified at a mean gestational age of 21 (range, 13–37) weeks. The majority of cases (97%) had bilateral hyperechogenic kidneys. In the 265 cases with available follow‐up data, other associated renal tract abnormalities were identified prenatally in 36%, concomitant extrarenal structural abnormalities in 39% and abnormal karyotype in 15% of cases. Of the 316 included cases, 139 did not survive, including 105 terminations of pregnancy, five intrauterine deaths and 29 early neonatal deaths. Only 4.3% (6/139) of these fetuses had isolated hyperechogenic kidneys while 28.1% (39/139) had associated multiple renal tract abnormalities alongside hyperechogenic kidneys and over two‐thirds (67.6%; 94/139) had concomitant extrarenal abnormalities. Of the 177 cases that survived beyond 1 month of age, outcome data were available in 126. Of these, based on the antenatal findings, 60 (47.6%) cases had isolated hyperechogenic kidneys, 56 (44.4%) had associated renal structural abnormalities and 10 (7.9%) had additional extrarenal abnormalities. Considering renal outcome alone, kidney function was abnormal in 13 (21.7%), 10 (17.9%) and 0 (0%) infants in these three groups, respectively, although concurrent pathology clearly affected global outcome in the more complex cases. Neonatal mortality of 1.6% was observed in the isolated renal hyperechogenicity group. The presence of oligohydramnios or abnormal renal volume was not associated significantly with abnormal renal function (odds ratio (OR), 2.32 (99% CI, 0.54–10.02) and OR, 0.74 (99% CI, 0.21–2.59), respectively) in this group.Conclusions: Hyperechogenic kidneys are often complicated by associated renal tract and extrarenal abnormalities, aberrant karyotype and genetic disease, and these factors have a greater effect on overall outcome than does kidney echogenicity. The renal outcome of fetuses with isolated hyperechogenic kidneys is good generally, with over 70% of cases having normal renal function postpartum. Importantly, for prognostic counseling, all of the fetuses in this non‐selected series with isolated hyperechogenic kidneys and normal amniotic fluid levels had normal renal outcome in infancy. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

22 January 2022 in Case Reports in Women's Health
Verified
Journal Article
Open access
DPDeesha Patel
Deesha Patel
AYAngela Yulia
Angela Yulia

15 April 2020 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
AYAngela Yulia
Angela Yulia
SPSona Pawar
Sona Pawar
OCOana Chelemen
Oana Chelemen
FUFred Ushakov
Fred Ushakov
PPPranav P. Pandya
Pranav P. Pandya

30 November 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AYAngela Yulia
Angela Yulia
AVAlice J. Varley
Alice J. Varley
NSNatasha Singh
Natasha Singh
KLKaiyu Lei
Kaiyu Lei
RTRachel Tribe
Rachel Tribe
MJMark R Johnson
Mark R Johnson
We previously reported that at term pregnancy, a decline in myometrial protein kinase A (PKA) activity leads to an exchange protein activated by cyclic AMP (Epac1)-dependent increase in oxytocin receptor (OTR) expression, promoting the onset of labour. Here, we studied the changes in the cyclic adenosine monophosphate (cAMP) effector system present in different phenotypes of preterm labour (PTL). Myometrial biopsies obtained from women with phenotypically distinct forms of PTL and the levels of PKA and OTR were examined. Although we found similar changes in the cAMP effector pathway in all forms of PTL, only in the case of twin PTL (T-PTL) was myometrial OTR levels increased in association with these results. Although there were several changes in the mRNA levels of components of the cAMP synthetic pathway, the total myometrial cAMP levels did not change with the onset of any subtype of PTL. With regards to the expression of cAMP-responsive genes, we found that the mRNA levels of 4 of the 5 cAMP-down-regulated genes were increased in T-PTL, similar to our findings in term labour. These data signify that although changes in the cAMP effector system were common to all forms of PTL, only in T-PTL were OTR levels increased. Similarly, the mRNA levels of cAMP-repressed genes were only increased in T-PTL supporting the concept that the decline in PKA levels influences myometrial function driving the onset of T-PTL.

5 April 2019 in Case Reports in Perinatal Medicine
Verified
Journal Article
Closed access
PDF file
AYAngela Yulia
Angela Yulia
OCOana Chelemen
Oana Chelemen
RBRuchi Bhutani
Ruchi Bhutani
CHCiaran Hutchinson
Ciaran Hutchinson
SLSamantha Levine
Samantha Levine
RWRuwan Wimalasundera
Ruwan Wimalasundera
Background: Placenta chorioangiomas are common benign placental tumours. While microscopic chorioangiomas are frequent, macroscopic chorioangiomas of more than 5 cm are rare and often associated with fetal complications such as high output cardiac failure, fetal anaemia and stillbirth. Close monitoring and in-utero treatment are sometimes necessary to prevent adverse pregnancy outcome. Case presentation: We present two cases of large placenta chorioangiomas with one case requiring surgical therapy with radiofrequency ablation (RFA) of tumour vessels, which resulted in a successful outcome of a live birth at term. Conclusion: We conclude that RFA is an effective alternative treatment modality to fetoscopic laser therapy in utero for cases at risk of fetal cardiac failure and intrauterine demise in the presence of large chorioangiomas.